Monocytes of distinct clinical types of leprosy are differentially activated by cross-linking class II HLA molecules to secrete IL-12

APMIS

Volumn 112, Issue 4-5, 2004, Pages 271-274

  Ohyama, Hideki ^a   Kato, Nahoko ^b   Takeuchi, Kazu ^b   Soga, Yoshihiko ^b   Uemura, Yasushi ^a   Nishimura, Fusanori ^b   Matsushita, Sho ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cellular immune response; Class II HLA; IL 12; Leprosy patients

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 2; INTERLEUKIN 12; INTERLEUKIN 1BETA;

ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEPROMATOUS LEPROSY; MONOCYTE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUBERCULOID LEPROSY;

CYTOKINES; HLA-D ANTIGENS; HUMANS; INTERLEUKIN-12; LEPROSY; LEUKOCYTES, MONONUCLEAR; REFERENCE VALUES;

EID: 3442889451     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2004.apm11204-0507.x     Document Type: Article

References (9)

1. Ridley DS, Jopling WH. Classification of leprosy according to immunity: a five-group system. Int J Lepr 1966;34:255-73.
2. Sieling PA, Wang XH, Gately MK, Oliveros JL, McHugh T, Barnes PF, et al. IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol 1994;153:3639-47.
3. Sieling PA, Modlin RL. Cytokine patterns at the site of mycobacterial infection. Immunobiology 1994;191:378-87.
4. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999;285: 732-6.
5. Kang TJ, Lee SB, Chae GT. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 2002;20:56-62.
6. Matsuoka T, Tabata H, Matsushita S. Monocytes are differentially activated through HLA-DR, -DQ, and -DP molecules via mitogen-activated protein kinases. J Immunol 2001;166:2202-8.
7. Matsuoka T, Kohrogi H, Ando M, Nishimura Y, Matsushita S. Altered TCR ligands affect antigen-presenting cell responses: up-regulation of IL-12 by an analogue peptide. J Immunol 1996; 157:4837-43.
8. Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR, et al. Massive gene decay in the leprosy bacillus. Nature 2001;409: 1007-11.
9. Ohyama H, Matsushita S, Nishimura F, Kato N, Hatano K, Takashiba S, et al. T cell responses to major membrane protein II (MMP II) of Mycobacterium leprae are restricted by HLA-DR molecules in patients with leprosy. Vaccine 2001; 20475-82.